Novo Nordisk A/S Chief Executive Officer Mike Doustdar may have lost out to Pfizer Inc. in a $10 billion takeover battle for obesity drug developer Metsera Inc. But dont expect him to give up on deal… [+416 chars]Read More
Novos CEO Turns to Next Targets After Losing Metsera to Pfizer Bloombergcom
